Posted on 01/08/2024 10:03:15 AM PST by mac_truck
Moderna Inc.’s stock was up by 1.2% after the drug maker said it sold $6.7 billion of products in 2023. Analyst expected the company to sell $6.35 billion in products in 2023. Moderna said its share of the U.S. COVID-19 drug market was 48% in 2023, up from 37% in 2022. It also continues to expect 2024 product sales of approximately $4 billion, compared to the analyst estimate of $4.4 billion. It continues to expect it will return to sales growth in 2025, and break even in 2026. Moderna is also working on nine late-stage drug programs with anticipated milestones in 2024 and 2025.
(Excerpt) Read more at msn.com ...
Medicine tied to sales and a stock price. What could possibly go wrong?
The first thing authoritarians working on an insecticide for use against deplorable humans needs, is for their own protection from the same. The only reason many of us are still alive is that the cure or vaccine didn’t work. Once they have a lethal pathogen where a vaccine is 100% effective in protection, most of us are going to die.
Peaked in 2021 at $449
Now at $115
In related news, AARP is recommending that its members get an 8th COVID shot.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.